Promoting highly active antiretroviral therapy for HIV/AIDS patients

( views:, downloads: )
Author:
LU Hong-zhou(Public Health Clinical Center Affiliated to Fudan University,Shanghai 201508,China)
WANG Zhen-yan(Public Health Clinical Center Affiliated to Fudan University,Shanghai 201508,China)
Journal Title:
CHINESE JOURNAL OF CLINICAL INFECTIOUS DISEASES
Issue:
Volume 2, Issue 03, 2009
DOI:
10.3760/cma.j.issn.1674-2397.2009.03.001
Key Word:
Acquired immunodeficiency syndrome;Highly active antiretroviral therapy;CD4+ T lymphocytes

Abstract´╝Ü

  • [1]Antiretroviral Therapy Cohort Collaboration.Life expectancy of individuals on combination antiretroviral therapy in high-inceme countries:a collaborative analysis of 14 cohort studies.Lancet,2008,372 (9635):293-299.
  • [2]MacArthur RD,Novak RM,Peng G,et al.A comparison of three highly active antiretroviral treatment strategies consisting of nonnucleoeide revense transcriptase inhibitors,protease inhibitor,or both in the presence of nucleoside reverse transcriptese inhibitors as initial therapy (CPCBA 058 FIRST Study):a long-term randomised trial.Lancet,2006,368(9553):2125-2135.
  • [3]Nozza S,Visco F,Soria A,et al.Excellent short-term CD4 recovery with a PI-and NRTI-sparing regimen in triple-class failure HIV-infected patients:raltegravir,maraviroc,etravirine//Ninth International Congress on Drug Therapy in HIV Infection Glasgow,UK.9-13 November 2008.J Int AIDS Soc,2008,11(Suppl 1):P45.
  • [4]Sterne J,May M,Costagliola D,et al.Estimating the optimum CD4 threshold for starting HAART in ART-naive HIV-infected individuals.Conf Retrovir Opportunistic Infect,2006,13:abstract no.525.
  • [5]Violari A,Cotton MF,Gibb DM,et al.Early antiretroviral therapy and mortality among HIV-infected infants.N Engl J Med.2008,359(21):2233-2244.
  • [6]Malinearne E,Sgrelli A,Camanni G,et al.Immune restoration during HAART:8-yesr follow-up in HIV-pesitive patients with sustained virolagical suppression//Ninth International Congress on Drug Therapy in HIV Infection Glasgow,UK.9-13 November 2008.J Int AIDS Soc,2008,11(Suppl 1):P10.
  • [7]Gras L,Kesselring AM,Griffin JT,et al.CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater.J Acquir Immune Defic Syndr,2007,45(2):183-192.
  • [8]The Strategies for Management of Antiretroviral Therapy (SMART)Study Group,EI-Sadr WM,Lundgren JD,et al.CD4+ count guided interruption of antiretroviral treatment.N Engl J Med,2006,355(22):2283-2296.
  • [9]Maggiolo F,Airoldi M,Callegaro A,et al.CD4-guided STI in patients responding to HAART//Ninth International Congress on Drug Therapy in HIV Infection Glasgow,UK.9-13 November 2008.J Int AIDS Soc,2008,11(Suppl 1):O19.
  • [10]Paterson DL,Swindells S,Mohr J,et al.Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.Ann Intern Med,2000,133(1):21-30.
  • [11]Bangsberg DR.Less than 95% adherence to nonnueleeside reverse-transcriptase inhibitor therapy can lead to viral suppression.Clin Infect Dis,2006,43(7):939-941.
  • [12]Martin M,Del Cacho E,Codina C,et al.Relationship between adherence level,type of the antirctroviral regimen,and plasma HIV type 1 RNA viral load:a prospective cohort study.AIDS Res Hum Retroviruses,2008,24(10):1263-1268.
  • [13]Tam LW,Chni CK,Brunnno CJ,et al.The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individuals drug classes.J Acqnir Immune Defic Syndr,2008,49(3):266-271.
  • [14]Cohen C,Colson A,Pierone G,et al.The FOTO study:24-week results support the safety of a 2-day break on efavirenz-based antiretroviral therapy//Ninth International Congress on Drug Therapy in HIV Infection Glasguw,UK.9-13 November 2008.J Int AIDS Soc,2008,11 (Suppl 1):O19.
  • [15]Castilla J,Del Romero J,Hernando V,et al.Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV.J Acquir Immune Defic Syndr,2005,40(1):96-101.
  • [16]Granich RM,Gilks CF,Dye C,et al.Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission:a mathematical model.Lancet,2009,373(9657):48-57.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn